Utilizing an Animal Model to Identify Brain Neurodegeneration-Related Biomarkers in Aging

Area of Science:

• Neuroscience
• Biochemistry
• Molecular Biology

Background:

• Glycine N-methyltransferase (GNMT) plays a crucial role in regulating S-adenosylmethionine (SAMe) levels.
• Elevated SAMe is linked to reduced neurogenic capacity and memory deficits.
• Understanding GNMT's impact on neuronal health is vital for addressing age-related cognitive decline.

Purpose of the Study:

• To investigate the proteomic changes in the brain of Glycine N-methyltransferase knockout (GNMT-KO) mice.
• To identify age-dependent and age-independent protein alterations associated with GNMT deficiency.
• To explore potential therapeutic targets for neurodegenerative diseases and aging.

Main Methods:

• Proteomic analysis of brain tissues from GNMT-KO and wild-type mice.
• Haematoxylin and Eosin staining and immunohistochemistry.
• Western blotting and Ingenuity Pathway Analysis (IPA).

Main Results:

• Receptor-interacting protein 1 (RIPK1) and Caspase 3 were upregulated, while activity-dependent neuroprotective protein (ADNP) was downregulated in GNMT-KO mice.
• Specific proteins associated with neuropathology, neuronal function, and neurodegenerative disorders were identified in different age groups and genotypes.
• Proteomic analysis revealed an association between the Gonadotropin-releasing hormone (GnRH) signaling pathway and aging.

Conclusions:

• GNMT deficiency leads to significant alterations in brain protein expression, affecting neuronal function and potentially contributing to neurodegeneration.
• Identified protein markers may serve as biomarkers for aging and neurodegenerative conditions.
• The GnRH pathway warrants further investigation for its role in aging and neurodegeneration, offering potential avenues for therapeutic intervention.